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Summary
Objective: Chondrocytes exhibit speciﬁc responses to bone morphogenetic proteins (BMPs) and transforming growth factor-bs (TGF-bs). The
bioactivity of these growth factors is regulated by numerous mediators. In our previous study, Smad1 was found to interact with the cytoplas-
mic domain of the hyaluronan receptor CD44. The purpose of this study was to determine the ability of hyaluronan in the pericellular matrix to
modulate the chondrocyte responses to BMP-7 or TGF-b1.
Experimental design: Nuclear translocation of Smad1, Smad2 and Smad4 was studied in bovine articular chondrocytes in response to BMP-7
and TGF-b1. The effects of matrix disruption by hyaluronidase treatment and the initiation of matrix repair by the addition of hyaluronan on the
nuclear translocation of Smad proteins, Smad1 phosphorylation and luciferase expression by a CD44 reporter construct in response to BMP-7
were also studied.
Results: The disruption of the hyaluronan-dependent pericellular matrix of chondrocytes resulted in diminished nuclear translocation of endog-
enous Smad1 and Smad4 in response to BMP-7; however, the nuclear translocation of Smad2 and Smad4 in these matrix-depleted chondro-
cytes in response to TGF-b1 was not diminished. Incubation of the matrix-depleted chondrocytes with exogenous hyaluronan restored Smad1
and Smad4 nuclear translocation and increased pCD44(499)-Luc luciferase expression in response to BMP-7. Both exogenous hyaluronan
and matrix re-growth enhanced by hyaluronan synthase-2 (HAS2) transfection restored Smad1 phosphorylation.
Conclusions: Disruption of hyaluronaneCD44 interactions has little effect on the TGF-b responses; however, re-establishing CD44ehyalur-
onan ligation promotes a robust cellular response to BMP-7 by articular chondrocytes. Thus, changes in cellehyaluronan interactions may
serve as a mechanism to modulate cellular responsiveness to BMP-7.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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In articular cartilage, hyaluronan serves as the core ﬁlament
of the proteoglycan aggregate; these macromolecular ag-
gregates composed of hyaluronan, link protein and the ma-
jor cartilage proteoglycan, aggrecan, establish essential
biomechanical properties of cartilage1,2. The ability of hya-
luronan to inﬂuence cell behavior is due in part to its role
in the organization of the extracellular matrix (ECM) and
the capacity of hyaluronan to interact directly with cells3.
Hyaluronan synthase-2 (HAS2) is primarily responsible for
hyaluronan synthesis in articular chondrocytes4. CD44
serves as a primary transmembrane receptor for hyalur-
onan, providing cells a mechanism for matrix attachment
or for sensing changes in the ECM5. CD44 can also serve
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906membrane, the pericellular matrix or the cortical cytoplasm
but has no intrinsic kinase activity2,6. Therefore, CD44e
hyaluronan interactions link the ECM to elements of the cy-
toskeleton and other component proteins of signaling
pathways.
The transforming growth factor-b (TGF-b) superfamily in-
cludes the three isoforms of TGF-b, the activins and the
bone morphogenetic proteins (BMPs). These secreted pro-
teins are anabolic morphogens and growth factors with crit-
ical functions for the articular joint7. BMP-7 is synthesized
by articular chondrocytes8, has been shown to upregulate
the expression of CD449,10 as well as the expression of
HAS29,10 and aggrecan9e11 by chondrocytes resulting in
enhanced ECM deposition and retention.
The receptors for the TGF-b superfamily are serine/thre-
onine kinases, termed type I and type II receptors. The ac-
tive BMP-7 receptor complex consists of a BMP-7 dimer,
two type I (ALK2) receptors and two type II (ActR-II) recep-
tors12. Substrates for type I receptors include members of
the Smad protein family13. The common BMPs utilize
Smad1, Smad5, Smad8 as signaling partners whereas
TGF-bs utilize Smad2 or Smad314 which upon phosphoryla-
tion form complexes with Smad4 that undergo nuclear
translocation as an early cellular response to stimulation.
BMP-7 and BMP-6 activate Smad1 and Smad5 but not
Fig. 1. Smad1 immunolocalization in bovine articular chondrocytes following BMP-7 or TGF-b1 stimulation. Immunostaining of endogenous
Smad1 used a polyclonal antibody that recognizes Smad1 in both a non-phosphorylated and phosphorylated state and a rhodamine red-con-
jugated secondary antibody. Chondrocytes were cultured in media with 0.5% FBS and stimulated for 1 h with BMP-7 (A, C, E) or TGF-b1 (B,
D, F) then stained; DAPI was used as a nuclear marker (A, B). Scale bars equal 10 mm. False colors (E, F) enhance the nuclear/cytoplasmic
interface. Maximal pixel intensity was determined at point values taken within regions of the nucleus and cytoplasm, equivalent to areas
denoted by arrows (E, F) and mean pixel intensity was determined within equivalent rectangular regions of the nucleus and cytoplasm, ex-
empliﬁed by the rectangles (E). An increase in the ratio of pixel intensity in the nucleus:cytoplasm reﬂects nuclear translocation of Smad1;
see also Table I. A ﬂuorescent intensity proﬁle along a line segment that intersected the plasma membrane twice and the nucleus twice,
with the two endpoints outside the cell (E, F) was plotted along the x-axis (G, H) in the direction indicated by the arrowhead.
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Table I
Morphometric analysis of cellular distribution of Smad1, Smad2 and
Smad4 in bovine articular chondrocytes
Sample Ratio* n-value Ratioy n-value
A. Untreated control chondrocytes
Smad1 1.03 0.12 13 1.06 0.16 16
Smad2 1.21 0.19 12 1.09 0.08 12
Smad4 1.27 0.11 12 1.19 0.14 15
B. Chondrocytes treated with BMP-7
Smad1 1.78 0.27z 16 1.57 0.22 23z
Smad4 2.16 0.60z 18 1.80 0.32 21z
C. Chondrocytes treated with TGF-b1
Smad1 1.04 0.19 14 1.06 0.18 13
Smad2 1.69 0.29z 29 1.58 0.21 23z
Smad4 1.51 0.19z 19 1.29 0.09
(0.0108)
23z
D. Chondrocytes pre-treated with SHase
Smad1 after BMP-7 1.05 0.04 13 1.06 0.07 18
Smad4 after BMP-7 1.15 0.17 12 1.07 0.15 17
Smad1 after TGF-b 1.12 0.07 17 1.21 0.23 18
Smad2 after TGF-b 1.82 0.21z 11 1.68 0.27 14z
Smad4 after TGF-b 1.62 0.16z 19 1.40 0.17
(0.0003)
24z
908 R. A. Andhare et al.: Hyaluronan promotes BMP-7 responsesSmad815. Signaling is dependent on the bioavailability of
BMPs to the cognate receptors16 as well as Smad
proteins17.
In our previous study18, a yeast-two hybrid screen and
co-immunoprecipitation studies revealed an interaction be-
tween Smad1 and CD44, which was reduced after BMP-7
stimulation. The disruption of hyaluronan binding to CD44,
either by Streptomyces hyaluronidase treatment or over-ex-
pression of a dominant negative CD44HD67 or truncated
CD44HD54, resulted in diminished responses to BMP-7;
these results support a functional link between the canonical
BMP-7/BMP-R/Smad1 signaling pathway and endogenous
hyaluronaneCD44 interactions.
Chondrocytes may sense and respond to changes in the
ECM in part via hyaluronaneCD44 interactions. This study
investigates hyaluronaneCD44 interactions on the
Smad1/4 response initiated in articular chondrocytes by
BMP-7 as compared with the Smad2/4 response by
chondrocytes after TGF-b1 treatment. Our results suggest
that disruption of hyaluronanechondrocyte interactions
has little effect on TGF-b1 responses, but establishing or
re-establishing CD44ehyaluronan ligation promotes
a robust cellular response to BMP-7 thus distinguishing
the effect of the ECM on the response of chondrocytes to
these two anabolic factors.E. Chondrocytes pre-treated with SHase followed by HA add-back
Smad1 after BMP-7 1.58 0.15z 15 1.57 0.26 26zMaterials and methods
Smad4 after BMP-7 1.57 0.20z 23 1.59 0.21 37zCELL CULTURE
*Values represent the average ratio of maximal pixel intensity
(nucleusO cytoplasm)S.D. for each cell condition. Maximal pixel
intensity was determined at point values taken within regions of the
nucleus and cytoplasm, equivalent to areas denoted by arrows in
Fig. 1(E, F).
yValues represent the average ratio of mean pixel intensity
(nucleusO cytoplasm)S.D. for each cell condition. Mean pixel
intensity was determined within equivalent rectangular regions of
the nucleus and cytoplasm as denoted by rectangles in Fig. 1(E).
zDenotes averages that are statistically different from control
condition (P< 0.0001) as measured using an unpaired Student’s
t test unless otherwise stated in parentheses.Bovine articular chondrocytes were isolated from metacarpophalangeal
joints of 18-month-old animals (full thickness slices) by sequential incubation
in 0.2% Pronase (Calbiochem) for 1 h and 0.0025% collagenase (Roche) for
16 h. The chondrocytes were cultured in DMEM/F12, with 10% FBS and
1 mg/ml ascorbic acid prior to initiation of experimental conditions to allow
for optimal recovery19. Prior to stimulation with growth factors, the chondro-
cytes were cultured in low-serum-containing media (0.5% FBS) for an addi-
tional 24 h. Then the chondrocytes were stimulated for 1 h with 100 ng/ml
BMP-7 or 5 ng/ml TGF-b1 (R&D Systems). To determine the effects of matrix
removal on growth factor responses, chondrocytes were pre-treated with
5 U/ml Streptomyces hyaluronidase (Sigma) 90 min to generate ‘‘matrix-de-
pleted’’ cells19. To determine the effects of exogenous hyaluronan on growth
factor responsiveness by matrix-depleted cells, these chondrocytes were
incubated with 100 mg/ml high molecular mass hyaluronan (Healon; Pharma-
cia Upjohn, North Peapack, NJ) prior to stimulation.IMMUNOCYTOCHEMISTRYBovine chondrocytes were plated into chamber slides, at 200,000 cells/
chamber, directly following isolation from cartilage. After stimulation with
BMP-7 or TGF-b1, with or without hyaluronidase pre-treatment or hyaluronan
add-back, the cells were ﬁxed with 2% paraformaldehyde, permeabilized
with 0.2% Triton-X-100 and then incubated overnight with anti-Smad1,
Smad2 or Smad4 polyclonal antibodies (Cell Signaling) in 10% goat se-
rum/1% BSA/PBS. Rhodamine red-X IgG (Jackson ImmunoResearch) was
used for detection and DAPI (Molecular Probes) as a nuclear counterstain.
In these studies, the anti-Smad antibodies that recognize both phosphory-
lated and non-phosphorylated forms were used. To detect BMP receptors,
chondrocytes were incubated with the ActR-IIA antibody or the BMPR-IB
antibody (Santa Cruz Biotechnology). The cells were viewed using a Nikon
Ellipse E600 microscope equipped with Y-Fl Epi-ﬂuorescence, PLAN-Apo-
chromat 1.4 NA/60x oil and PLAN 0.5 NA/20x objectives. Images were cap-
tured digitally in real time using a Spot-RT camera (Diagnostic Instruments;
Sterling Heights, MI) and processed using MetaView imaging software
(Molecular Devices; Sunnyvale, CA).
To investigate effects of cell shape on growth factor responsiveness,
chondrocytes cultured in alginate beads were stimulated with BMP-7 or
TGF-b1, with or without hyaluronidase pre-treatment, then also ﬁxed with
2% paraformaldehyde and permeabilized with 0.2% Triton-X-100 prior to re-
lease from the alginate beads using 55 mM NaCitrate containing 150 mM
NaCl to affect depolymerization of the alginate20. Following immunostaining,
these chondrocytes were mounted onto slides in medium containing DAPI.
A morphometric analysis of Smad nuclear translocation was performed on
single color images (red ﬂuorescence intensity ranging from 30 to 255
relative units) using NIS-Elements BR2.30 imaging software (Nikon) todetermine the ratio of pixel intensity in the nucleus vs pixel intensity in the
cytoplasm on a per cell basis. Maximal pixel intensity was determined at
point values taken within regions of the nucleus and cytoplasm, equivalent
to areas denoted by arrows in Fig. 1(E, F), with nuclear localization con-
ﬁrmed by DAPI-colocalization in overlay images (Ratio #1; Table I). These
data were conﬁrmed by two additional separate observers. As an alternative
approach, mean pixel intensity was determined within equivalent rectangular
regions of the nucleus and cytoplasm, exempliﬁed by the rectangles in
Fig. 1(E) (Ratio #2; Table I). Images viewed under high power oil typically
contained 3e5 cells per ﬁeld with 12e30 cells counted per condition (there-
fore w3e5 ﬁelds per condition). For untreated chondrocytes the ratio of nu-
clear to cytoplasmic staining for Smad1, Smad2 and Smad4 ranged from
1.03 to 1.27 representing a lack of deﬁned nuclear staining or primarily cyto-
plasmic staining. After treatment with BMP-7, the ratio of nuclear to cytoplas-
mic staining for Smad1 and Smad4 ranged from 1.57 to 2.16 representing
nuclear localization of the Smad immunostaining.GENERATION OF CD44 LUCIFERASE REPORTER
CONSTRUCTSThe promoter region of the CD44 sequence (GenBank accession number
AL356215), intron/exon maps and the 50 untranslated region were identiﬁed,
mapped and analyzed using Proscan, ‘‘TESS’’ from http://www.cbil.upen-
n.edy/c-gibin/tess/tess and ‘‘MatInspector’’ from http://www.genomatix.de/
products/MatInspector/index.html and potential binding sites for Smad4,
Smad3, Smad1 and Egr-1 were identiﬁed. Based on these locations, a 50-de-
letion CD44 gene construct was generated using a sense primer engineered
to include the Nhe-1 enzyme restriction site (underlined) on the 50 end:
50 GCT AGC CCA AAG GCT GAA CCC AAT GG 30 and the antisense
909Osteoarthritis and Cartilage Vol. 17, No. 7primer: 50 CTC CTC GAG CAA AAC TTG TCC TTG GTG TCC 30. This
construct, designated pCD44(499)-Luc, is similar to the pBLCD44 construct
previously characterized and validated in studies of Egr-1 induction of
CD4421,22. High purity human genomic DNA (Promega) was PCR-ampliﬁed
using platinum Pfx DNA polymerase (Invitrogen) with an annealing temper-
ature of 65C and an extension temperature of 72C for 28 cycles. The prod-
ucts were again ampliﬁed by PCR using the AmpliTaq polymerase (Roche)
and ligated into a TOPO TA Cloning vector (Invitrogen). The CD44 insert was
then subcloned into a pGL3 Basic vector (Invitrogen) using enzymes Kpn-1
and Nhe-1. All inserts were veriﬁed by restriction digestion analysis and then
sequenced (Sequetech; Mountain View, CA). To assure the functional
activity of our pCD44(499)-Luc construct, and to compare its activity to
that described for pBLCD4421,22, it was tested in C-28/I2 cells. Treatment
of C-28/I2 cells transfected with pCD44(499)-Luc with BMP-7, IL-1a or
IL-1b resulted in a w50% increase in luciferase activity (data not shown)
indicating that responsive elements and the promoter segment were active
and capable of driving the expression of luciferase.TRANSIENT TRANSFECTION AND LUCIFERASE ASSAYIn order to improve transfection efﬁciency, bovine chondrocytes were pas-
saged twice using trypsin and then transfected in suspension with the
pCD44(499)-Luc construct in a 3:1 ratio with Lipofectamine2000 (Invitrogen).
Transfected cells were then subcultured within 3-D alginate bead cultures for
48 h to restore spherical morphology and intact pericellular matrix19. The
transfected chondrocytes (within the beads) can be incubated with growth
factors or with Streptomyces hyaluronidase prior to release and analysis,
however the ability of high molecular mass hyaluronan to penetrate into
the alginate beads is limited. Therefore, for hyaluronan add-back experi-
ments, chondrocytes were released from the beads, pre-incubated with or
without 100 ug/ml Healon and then treated with 100 ng/ml BMP-7 for 1 h.
Cell lysates were prepared with passive lysis buffer (Promega), aliquots
were mixed with luciferase assay reagent (Promega) and the relative ﬁreﬂy
luciferase units (RLU) were measured on a Sirius luminometer (Zylux Corpo-
ration). The RLU values were normalized to total protein in the lysates (Bio-
Rad Protein Assay).SH'ase/BMP-7 SH'a
Smad1 Smad
Control Con
BMP-7
A B
ED
G H
Fig. 2. Nuclear translocation of Smad1 in response to BMP-7 is matrix-dep
matrix independent in articular chondrocytes. Panels A, B, D, E, G, H sh
Panels C, F, I show the staining of endogenous Smad2 in bovine cho
(A, B, C) and then stimulated for 1 h with BMP-7 (D) or TGF-b1 (E, F). In p
idase to remove the pericellular matrix and then stimulated for 1 hWESTERN BLOT ANALYSESBovine chondrocytes in high density monolayer cultures in 10% FBS con-
taining media for 5 days and for the subsequent 24 h in 0.5% FBS containing
media were left untreated (controls) or pre-treated with 5 U/ml Streptomyces
hyaluronidase or 100 U/ml testicular hyaluronidase (Sigma H3506-1G) to
remove the pericellular matrix. The matrix-depleted chondrocytes were
next either stimulated directly with BMP-7 or incubated for 2 h in the pres-
ence of exogenous Healon prior to BMP-7 stimulation for 1 h.
As an alternative to hyaluronan add-back, chondrocytes were transfected
with a vector containing cDNA encoding full-length human HAS223 to en-
hance endogenous hyaluronan synthesis. Brieﬂy, after 5 days of culture,
chondrocytes were lifted with 0.1% Pronase/0.1% collagenase, transfected
using Lipofectamine2000 and cultured for 2 days of recovery. Control chon-
drocytes and HAS2-transfected chondrocytes were cultured overnight in se-
rum-free media and then left untreated (controls) or pre-treated with 100 U/ml
testicular hyaluronidase to remove the pericellular matrix and then incubated
for 2 h for matrix recovery prior to BMP-7 stimulation for 1 h.
Chondrocytes were lysed in 50 mM Tris, pH 7.4 with 150 mM NaCl, 3 mM
MgCl2, 0.5% NP-40 buffer, with protease (P2714, Sigma) and phosphatase
(P2850, Sigma) inhibitors for western blotting for total Smad1, phosphory-
lated Smad1 (ser463/465 phosphorylated-Smad1 antibody; Cell Signal-
ing)14,18 and b-actin (AC-15; Sigma). Biotinylated IgG (PIC-4000; Vector
Labs), followed by incubation with HRP-Streptavidin (Amersham) and the Lu-
minol Reagent (Santa Cruz Biotechnology) was used for detection. The re-
sultant band intensities were quantiﬁed using a Fluor-S imaging system
(Bio-Rad ).ResultsNUCLEAR TRANSLOCATION OF Smads IN ARTICULAR
CHONDROCYTESNuclear translocation of speciﬁc receptor-regulated
Smads (R-Smads) and Smad4 are early cellular responses
to stimulation by members of the TGF-b superfamily.TGF-β TGF-β
se/TGF-β SH'ase/TGF-β
1 Smad2
trol Control
C
F
I
endent but nuclear translocation of Smad2 in response to TGF-b1 is
ow the immunoﬂuorescence staining of endogenous Smad1 while
ndrocytes. Chondrocytes were cultured in media with 0.5% FBS
arallel, chondrocytes were pre-treated with Streptomyces hyaluron-
with BMP-7 (G) or TGF-b1 (H, I). Scale bars equal 10 mm.
SH'ase/BMP-7
Smad4
BMP-7 TGF-β
Control Control
Smad4
SH'ase/TGF-β
B
C D
FE
A
Fig. 3. Nuclear translocation of Smad4 in chondrocytes. Articular chondrocytes were cultured in media with 0.5% FBS (A, B) and then stim-
ulated for 1 h with BMP-7 (C) or TGF-b1 (D). In parallel, chondrocytes were pre-treated with Streptomyces hyaluronidase to remove the peri-
cellular matrix and then stimulated for 1 h with BMP-7 (E) or TGF-b1 (F). Scale bars equal 10 mm. The immunostaining patterns for Smad4
correlated with those for Smad1 and Smad2 under the treatment conditions; nuclear translocation of endogenous Smad4 in response to BMP-
7 is matrix-dependent but is matrix independent in response to TGF-b1.
910 R. A. Andhare et al.: Hyaluronan promotes BMP-7 responsesNuclear translocation of Smad1 occurred in response to
BMP-7 yielding prominent nuclear immunostaining of
Smad1 [Fig. 1(A, C, E)]. However, Smad1 immunostaining
remained predominantly in the cytoplasm following TGF-
b1 stimulation [Fig. 1(B, D, F)] indicating the speciﬁcity of
Smad1 activity. The ﬂuorescence intensity proﬁle along
the line segment intersecting the plasma membrane and
the nucleus [shown in Fig. 1(E, F)] shows peak nuclear
staining for Smad1 in response to BMP-7 [Fig. 1(G)] with
peak cytosolic staining and low nuclear staining for
Smad1 in chondrocytes following TGF-b1 stimulation
[Fig. 1(H)]. Endogenous Smad1 [Fig. 2(A, B)] and Smad2
[Fig. 2(C)] were both localized in the cytoplasm of quiescent
articular chondrocytes. While Smad1 undergoes nuclear
translation upon BMP-7 stimulation [Fig. 2(D)], Smad1 re-
mained cytosolic following TGF-b1 stimulation [Fig. 2(E)].However, following TGF-b1 stimulation prominent nuclear
staining of Smad2 was observed [Fig. 2(F)].THE PERICELLULAR MATRIX PROMOTES THE CHONDROCYTE
RESPONSE TO BMP-7 YET NOT TGF-b1Chondrocytes in culture assemble a proteoglycan-rich
pericellular matrix that is anchored by CD44ehyaluronan in-
teractions. Treatment of chondrocytes with Streptomyces
hyaluronidase to degrade hyaluronan speciﬁcally, results
in the release of the pericellular matrix, but cell surface
expression of CD44, as determined by ﬂow cytometry, is
unchanged19. Previously we documented that nuclear
translocation of Smad1 in response to BMP-7 occurred in
matrix-intact chondrocytes, but not in matrix-depleted chon-
drocytes18. To address whether the hyaluronan-dependent
Fig. 4. Addition of hyaluronan to matrix-depleted chondrocytes restores Smad1 and Smad4 nuclear translocation in response to BMP-7.
Untreated chondrocytes exhibit diffuse cytoplasmic staining for Smad1 (A) and Smad4 (B). Chondrocytes, pre-treated with Streptomyces
hyaluronidase to remove the pericellular matrix, continue to exhibit diffuse cytoplasmic staining for Smad1 after BMP-7 stimulation (C)
and for Smad4 after BMP-7 stimulation (D). However, addition of high molecular mass hyaluronan for 2 h to matrix-depleted chondrocytes
restored the nuclear translocation of Smad1 (E) as well as the nuclear translocation of Smad4 (F) following stimulation with BMP-7. Scale
bars equal 10 mm.
911Osteoarthritis and Cartilage Vol. 17, No. 7pericellular matrix also supports the activation of Smad2 re-
sulting in nuclear translocation, chondrocytes were pre-
treated with Streptomyces hyaluronidase to remove that
matrix, prior to BMP-7 or TGF-b1 treatment. In matrix-de-
pleted chondrocytes, treatment with BMP-7 no longer eli-
cited nuclear translocation of Smad1 [Fig. 2(G)]. However,
nuclear translocation of Smad2 after TGF-b1 stimulation
was found to occur in matrix-depleted chondrocytes
[Fig. 2(I)]. To study the impact of cell shape, these re-
sponses were compared with those of chondrocytes cul-
tured for 5 days in alginate beads20. Chondrocytes that
were cultured, pre-treated with Streptomyces hyaluronidase
and stimulated with TGF-b1 within alginate breads retained
speciﬁc nuclear translocation of Smad2. However, after
Streptomyces hyaluronidase pre-treatment, stimulation of
these matrix-depleted chondrocytes within the alginate
beads with BMP-7 no longer resulted in Smad1 nucleartranslocation (data not shown.) Thus, the cell shape differ-
ences between monolayer and alginate suspension culture
did not alter the responses to BMP-7 or TGF-b1. However,
these data suggest that hyaluronanechondrocyte interac-
tions do support signaling via Smad1 in the chondrocyte
response to BMP-7 but do not affect the Smad2 nuclear
translocation in the TGF-b signaling pathway.
Diffuse cytoplasmic staining of the endogenous co-media-
tor Smad4 was predominant in chondrocytes cultured under
low-serum conditions [Fig. 3(A, B)]. Nuclear translocation of
Smad4 occurred after a 1 h stimulation with either BMP-7
[Fig. 3(C)] or TGF-b1 [Fig. 3(D)]. Pre-treatment of chondro-
cytes with Streptomyces hyaluronidase to remove the peri-
cellular matrix diminished Smad4 nuclear translocation in
response to BMP-7 [Fig. 3(E)]. However, nuclear transloca-
tion of Smad4 in response to TGF-b1 occurred in matrix-de-
pleted chondrocytes [Fig. 3(F)] as Smad4 presumably was
912 R. A. Andhare et al.: Hyaluronan promotes BMP-7 responsespartnered with Smad2/3. As in previous studies, Streptomy-
ces hyaluronidase treatment did not alter the cell surface
immunostaining for CD44, ActR-II and BMPR-IB receptors
on these bovine articular chondrocytes (data not shown).ADDITION OF HYALURONAN TO MATRIX-DEPLETED
CHONDROCYTES RESTORES THE RESPONSES TO BMP-7Fig. 5. BMP-7 stimulation of pCD44(499)-Luc in chondrocytes is
matrix-dependent. Open bars: the pCD44(499)-Luc-transfected
chondrocytes were cultured and treated within alginate beads.
Stimulation of matrix-intact chondrocytes with BMP-7 for 1 h re-
sulted in enhanced expression of luciferase as compared to non-
treated controls (Ctr). Treatment with Streptomyces hyaluronidase
alone did not alter the basal activity (SH); however following matrix
disruption, BMP-7 treatment no longer resulted in enhanced lucifer-
ase activity (SHþBMP-7). This suggests that disruption of hyalur-
onaneCD44 interactions reduces the response to BMP-7
stimulation. Hatched bars: due to limited penetration of hyaluronan
into the alginate beads, pCD44(499)-Luc-transfected chondrocytes
were released from the beads, pre-incubated with or without high
molecular mass hyaluronan and then treated with BMP-7 for 1 h.
Stimulation of matrix-intact chondrocytes with BMP-7 resulted in
enhanced expression of luciferase as compared to non-treated
controls (Ctr). After pre-treatment with Streptomyces hyaluronidase
followed by a 2 h recovery in media, a reduced response to BMP-7
stimulation was still observed (SHþBMP-7). However, the addition
of exogenous hyaluronan to the matrix-depleted chondrocytes for
2 h restored the BMP-7 response of increased luciferase activity
(SHþHAþBMP-7). The relative luciferase units (RLU) values
were normalized to total protein in the lysates obtained from threeAttempted matrix repair may occur in early stages of os-
teoarthritis. Matrix-depleted chondrocytes were incubated
for 2 h in the presence or absence of 100 mg/ml Healon to
mimic initial matrix repair, and then treated with BMP-7 for
1 h. Untreated bovine articular chondrocytes exhibit diffuse
cytoplasmic staining for both Smad1 [Fig. 4(A)] and Smad4
[Fig. 4(B)]. Chondrocytes pre-treated with Streptomyces
hyaluronidase followed by BMP-7 stimulation continued to
exhibit diffuse cytoplasmic staining for Smad1 [Fig. 4(C)]
and Smad4 [Fig. 4(D)]. However, the addition of hyaluronan
to matrix-depleted chondrocytes restored the nuclear trans-
location of Smad1 [Fig. 4(E)] and Smad4 [Fig. 4(F)] follow-
ing stimulation with BMP-7. Thus, these results suggest that
CD44 receptor occupancy with its ligand, hyaluronan, sup-
ports the functional participation of CD44 in the activation of
Smads1/4 in the BMP-7 signal transduction pathway result-
ing in nuclear translocation of Smads1/4.
A morphometric analysis of the cellular distribution of
Smad1, Smad2 and Smad4 in bovine articular chondro-
cytes determined the maximal pixel intensity at point values
(arrows) or mean pixel intensity (rectangles) within regions
of the nucleus and cytoplasm [Fig. 1(E, F)]. This analysis
(Table I) indicated that strong immunostaining for nuclear
Smad2 and Smad4 in response to TGF-b persisted even
though chondrocytes were pre-treated with Streptomyces
hyaluronidase, but that this enzymatic removal of the peri-
cellular matrix reduced nuclear immunostaining of Smad1
and Smad4 in the BMP-7 treatment groups to that observed
in untreated controls. The addition of exogenous hyalur-
onan to matrix-depleted chondrocytes restored the strong
nuclear immunostaining for Smad1 and Smad4 in response
to BMP-7 stimulation.replicate experiments of all conditions; average RLUS.D. are
shown. *P< 0.05 by t test.BMP-7 STIMULATION OF CD44 EXPRESSIONSince BMP-7 upregulates CD44mRNA expression in artic-
ular chondrocytes, a 50-deletion CD44 gene construct
containing potential binding sites for Smad4 and Smad1
was generated, designated pCD44(499)-Luc. Bovine chon-
drocytes were transfected with pCD44(499)-Luc, then estab-
lished in alginate bead cultures and incubated for 48 h. The
transfected chondrocytes within the alginate beads were
treated with BMP-7 with or without Streptomyces hyaluroni-
dase pre-treatment (Fig. 5, open bars) to study whether
matrix disruption would affect luciferase expression by this
CD44 reporter construct in response to BMP-7. Stimulation
of matrix-intact chondrocytes with BMP-7 for 1 h resulted in
enhanced expression of luciferase. Treatment with Strepto-
myces hyaluronidase alone did not alter the basal activity;
however following matrix disruption, BMP-7 treatment no
longer resulted in enhanced luciferase activity. This suggests
that disruption of hyaluronaneCD44 interactions reduces the
response to BMP-7 stimulation.
To test if responsiveness to BMP-7 could be restored with
restoration of hyaluronaneCD44 interactions, exogenous
high molecular mass hyaluronan was added to matrix-
depleted chondrocytes transfected with pCD44(499)-Luc.
However, due to limited penetration of hyaluronan into the
alginate beads, for hyaluronan add-back experiments,chondrocytes were released from the beads, pre-incubated
with or without hyaluronan and then treated with BMP-7 for
1 h (Fig. 5, hatched bars). A reduced response to BMP-7
stimulation was still observed after pre-treatment with Strep-
tomyces hyaluronidase followed by a 2 h recovery in media.
However, the addition of exogenous hyaluronan to the
matrix-depleted chondrocytes for 2 h restored the BMP-7
response of increased luciferase activity. This suggests
that hyaluronaneCD44 interactions can promote Smad-
dependent transcription following BMP-7 stimulation.WESTERN BLOT ANALYSIS OF Smad PHOSPHORYLATIONSignaling initiatedbyBMP-7binding to its receptors includes
Smad1 phosphorylation as detected studying matrix-intact
bovine chondrocytes18. Disruption of hyaluronaneCD44
interactions via Streptomyces hyaluronidase treatment18
or testicular hyaluronidase treatment reduced Smad1 phos-
phorylation upon BMP-7 stimulation (Fig. 6). The addition
of exogenous hyaluronan to matrix-depleted chondrocytes
was studied to mimic matrix repair and determine whether
Smad1 phosphorylation in response to BMP-7 stimulation
wouldbe restored.Asshown inFig. 6(C), afterapre-incubation
of matrix-depleted chondrocytes for 2 h with hyaluronan prior
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Fig. 6. Addition of hyaluronan to matrix-depleted chondrocytes re-
stores Smad1 phosphorylation in response to BMP-7. (AeC) Total
cell lysates were prepared from chondrocytes and analyzed by
SDS-PAGE and western blotting using an anti-phospho-Smad1 an-
tibody (upper panel), an anti-Smad1 antibody to detect total Smad1
(middle) and an anti-b-actin antibody (lower panel). In each, lysates
from control matrix-intact chondrocytes exhibited a weak band for
phospho-Smad1 (C), but a stronger band was detected from chon-
drocytes stimulated by BMP-7 (þ). (A) Chondrocytes were pre-
treated with Streptomyces hyaluronidase (SHase) to remove the
pericellular matrix, and then incubated for 2 h in the absence (S)
or presence (Sþ) of BMP-7. Smad1 phosphorylation was dimin-
ished in matrix-depleted chondrocytes. (B) Chondrocytes were
pre-treated with testicular hyaluronidase (THase) to remove the
pericellular matrix, and then incubated for 2 h in the absence (T)
or presence (Tþ) of BMP-7. Smad1 phosphorylation was dimin-
ished in matrix-depleted chondrocytes. (C) Streptomyces hyaluron-
idase (SHase) pre-treated chondrocytes were incubated in the
presence (S/HA/þ) or absence (Sþ) of exogenous hyaluronan prior
to BMP-7 stimulation. The addition of hyaluronan restored the
response to BMP-7 resulting in an increase in phospho-Smad1
(S/HA/þ). (D) The band intensities for total Smad1 and phospho-
Smad1 were normalized to that of b-actin from each lysate from
913Osteoarthritis and Cartilage Vol. 17, No. 7to treatmentwithBMP-7, these cells exhibited strong signal for
thephosphorylated-Smad1band.Setting the ratio of phospho-
Smad1:total Smad1 in the control lysates to 1.00, this analysis
showed Smad1 phosphorylation in response to BMP-7 in
matrix-intact chondrocytes, its reduction following matrix
depletion, and the restoration of Smad1 phosphorylation
following hyaluronan add-back to matrix-depleted chondro-
cytes [Fig. 6(D)].
As an alternative to exogenous hyaluronan add-back,
chondrocytes were transfected with full-length HAS2 in or-
der to enhance endogenous hyaluronan synthesis. Primary
chondrocytes or HAS2-transfected chondrocytes in mono-
layer culture were striped of matrix with testicular
hyaluronidase and then stimulated directly with BMP-7 or
incubated for 2 h for the re-growth of endogenous matrix
prior to stimulation with BMP-7. When stimulated with
BMP-7 directly following matrix depletion, both primary
chondrocytes and HAS2-transfected chondrocytes showed
reduced Smad1 phosphorylation (Fig. 7). Primary chondro-
cytes showed little recovery of the Smad1 phosphorylation
response, but the HAS2-transfected chondrocyte cultures
exhibited a recovery of BMP-7-induced Smad1 phosphory-
lation given 2 h of incubation for endogenous matrix re-
growth (Fig. 7). This suggests that matrix repair, especially
enhanced matrix repair due to over-expression of HAS2,
can restore BMP-7 responsiveness of chondrocytes.Discussion
CD44ehyaluronan interactions mediate a variety of cell
behaviors, including proliferation, migration and matrix re-
modeling. Several studies suggest mechanisms by which
the formation and/or uncoupling of hyaluronaneCD44 inter-
actions may modulate cell behavior5,18,24e26 and these in-
teractions may impact on cartilage homeostasis as
chondrocytes progress through cycles of ECM degradation
and attempted repair.
Native hyaluronan reduced mitogen-induced cell cycle
progression by smooth muscle cells whereas fragmented
hyaluronan was pro-mitogenic by opposite effects on cyclin
D1 mRNA expression27. BMP-7 was shown to induce p21
transcription, requiring an intact Smad signaling pathway28.
Thus as an alternative biological outcome, we determined
p21 expression in matrix-depleted and matrix-intact human
articular chondrocytes following BMP-7 stimulation (data
not shown). Our initial results suggest that an intact pericel-
lular matrix supports the increase in p21 mRNA following
BMP-7 treatment of human chondrocytes whereas p21
mRNA expression was decreased after hyaluronidase treat-
ment plus BMP-7 stimulation as compared to matrix-intact
untreated controls. Thus matrix depletion might enhance
proliferation whereas endogenous BMP-7 signaling to
maintain an intact pericellular matrix may promote the low
proliferative phenotype of articular chondrocytes.
We previously reported the binding of Smad1 with CD44,
supporting a functional link between the canonical BMP-7three separate experiments. Setting the ratio of the band intensity
for phospho-Smad1 to total Smad1 in the control (C) lysates to
1.00, the ratios were calculated for the other culture conditions
and data are presented as fold-increase. Stimulation by BMP-7 of
matrix-intact chondrocytes (þ) or matrix-depleted chondrocytes fol-
lowing hyaluronan add-back (S/HA/þ) resulted in an increase in
phospho-Smad1. Matrix-depleted chondrocytes did not exhibit the
BMP-7 response of Smad1 phosphorylation (Sþ).
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Fig. 7. Chondrocyte matrix re-growth following hyaluronidase treat-
ment restores Smad1 phosphorylation in response to BMP-7. As an
alternative to exogenous hyaluronan add-back, (A) primary chon-
drocytes or (B) HAS2-transfected chondrocytes in monolayer cul-
ture for 48 h were striped of matrix with testicular hyaluronidase
(T) and then either stimulated directly with BMP-7 (Tþ) or incubated
for 2 h for the re-growth of endogenous matrix prior to stimulation
with BMP-7 (2hrTþ). Total cell lysates were prepared from chon-
drocytes and analyzed by SDS-PAGE and western blotting using
an anti-phospho-Smad1 antibody (upper panel), an anti-Smad1 an-
tibody to detect total Smad1 (middle) and an anti-b-actin antibody
(lower panel). (A) Matrix-intact cultures of primary chondrocytes
exhibited Smad1 phosphorylation after BMP-7 stimulation (þ) com-
pared to non-BMP-7-stimulated control cultures (C). Matrix-de-
pleted chondrocytes stimulated with BMP-7 directly following
enzymatic treatment showed a weak Smad1 phosphorylation re-
sponse (Tþ). However, after 2 h of incubation for endogenous ma-
trix re-growth, primary chondrocytes exhibited a slightly enhanced
response to BMP-7 stimulation (2hrTþ). (B) Matrix-intact cultures
of HAS2-transfected chondrocytes exhibited increased Smad1
phosphorylation after BMP-7 stimulation (þ) compared to non-
BMP-7-stimulated control cultures (C). HAS2-transfected chondro-
cytes showed a weak Smad1 phosphorylation response when
stimulated with BMP-7 directly following enzymatic treatment (Tþ)
whereas after 2 h of incubation for endogenous matrix re-growth,
the HAS2-transfected chondrocytes exhibit a recovery of Smad1
phosphorylation after BMP-7 stimulation (2hrTþ).
914 R. A. Andhare et al.: Hyaluronan promotes BMP-7 responsessignaling pathway and endogenous hyaluronaneCD44 in-
teractions18. HyaluronaneCD44 ligation may promote the
presentation of Smad1 to the cytoplasmic domain of the
BMP-7 receptor. Alternatively, unoccupied CD44 may se-
quester Smad1 in an inaccessible pool away from the
BMP-7 receptor. Although data at this point do not refute ei-
ther hypothesis, clearly the disruption of hyaluronan binding
to CD44 resulted in diminished responses to BMP-7 while
hyaluronan binding to chondrocytes augments the Smad1
phosphorylation that occurs in response to BMP-7 stimula-
tion as well as the subsequent nuclear translocation of
Smad1/Smad4. Linking the cytoplasmic domain of CD44
with the actin cytoskeleton through multiple protein interac-
tions may stabilize and/or promote clustering of CD44 in the
plasma membrane6,29 and support efﬁcient CD44ehyalur-
onan binding. Recently the structural motifs for radixin(FERM domain) binding to CD44 intracellular domain
(ICD) were identiﬁed30. These authors proposed that the
CD44 cytoplasmic tail bound to ERM proteins would still
be able to bind to Smad1. They also conﬁrmed our earlier
suggestion18 that following proteolysis the cytosolic CD44
ICD together with Smad1 could cooperate with p300/CBP
to regulate transcriptional activation. Thus the Smad1 sig-
naling pathway may also be linked to the ICD-dependent
pathway of CD44 signaling.
The bioavailability of TGF-b/BMPs is regulated by a vari-
ety of mechanisms. Other proteins have been shown to
function in the presentation or sequestration of R-Smads13.
These include SARA for Smad2/Smad3 in the TGF-b signal-
ing pathway31 and endoﬁn a scaffold protein for the Smad2/
Smad4 complex in TGF-b signaling32 that also binds
Smad1 enhancing its phosphorylation and signaling33. Sol-
uble extracellular antagonists including noggin, follistatin
and chordin bind directly to BMPs to block receptor interac-
tions and endogenous BMP-7 regulates noggin and follista-
tin expression34. Binding of Kielin/Chordin-like Protein
(KCP) increases the binding of BMP-7 to its receptor but
KCP binding to TGF-b1 blocks Smad2 phosphorylation35.
Matrix molecules including decorin and biglycan and cell
surface proteoglycans are not dedicated modulators of
TGF-b/BMP signaling, but also contribute to regulation of bi-
oavailability36e38. However, the effective participation of
CD44 in Smad1 signaling combines its binding to Smad1
modulated by hyaluronan binding.
Although BMPs and TGF-bs have overlapping anabolic
activities and signiﬁcant interplay, other results suggest
a ‘‘division of labor’’ among the various members of the
TGF-b/BMP superfamily39. Differences in the potency of
BMPs or TGF-b to induce cartilage as well as differential
stimulation of proteoglycans and other cartilage matrix com-
ponents have been reported39,40. Alteration of the relative
magnitude of these TGF-b and BMP signals can disturb
cartilage homeostasis and induce differentiation or terminal
maturation41. In our study, although matrix-depleted chon-
drocytes exhibited a poor response to BMP-7, these cells
remained responsive TGF-b1. Matrix repair, enhanced by
hyaluronan or increased expression of HAS2 restored the
BMP-7 response. These results suggest that changes in hy-
aluronaneCD44 interactions may modulate speciﬁcally the
cellular responsiveness to BMP-7 or other BMPs that signal
through the Smad1-dependent canonical pathway thus dis-
tinguishing the effect of hyaluronan on the response of
chondrocytes to members of the TGF superfamily. Hyalur-
onan may inﬂuence the morphogenetic gradient for BMPs
and promote a robust activity perpetuated by a BMP-driven
positive feedback loop, with BMP-7 stimulating CD44 and
HAS2 synthesis, hyaluronan production and the BMP-7 re-
sponse through the ligation of hyaluronan with CD44.
The effective local concentration of BMPs and TGF-bs is
not merely the amount of the growth factor present, but de-
pends upon ECM components, cell surface receptors and
cytosolic signaling cascade molecules that modulate the
ability of cells to respond. Subtle changes in the ECM
can result in distinct changes in chondrocyte metabo-
lism26,42,43. The underlying mechanism of the diminished
response of osteoarthritic chondrocytes to local growth fac-
tors may explain, in part, the reduced capacity of these
cells to maintain the critical balance of ECM synthesis
and degradation7,8. The continuing progression of matrix
degeneration would decrease the cell-matrix interactions,
including cleavage and shedding of CD4429,44 that could
result in a less robust response to BMP-7, thus promoting
the downward spiral of osteoarthritis. Conversely, our data
915Osteoarthritis and Cartilage Vol. 17, No. 7suggest that increased synthesis of hyaluronan by HAS2 in
chondrocytes expressing CD44 would enhance the assem-
bly and retention of a pericellular coat9,10 and, in turn, pro-
mote the chondrocyte response to BMP-7. Thus matrix
repair that restores the ligation of hyaluronan with recep-
tors on chondrocytes may restore signaling pathways and
cartilage homeostasis.Conﬂict of interest
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